# Biomat USA Inc – FDA Inspection, Aug 24, 2018

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/059962c2-b91a-4197-b679-f4fb7a9034ef
Source feed: FDA_Inspections

> FDA inspection 1063182 of Biomat USA Inc, August 24, 2018. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 606. Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1063182
- Company Name: Biomat USA Inc
- Inspection Date: 2018-08-24
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1173782 - 2022-06-23
- FDA Inspection 932372 - 2015-06-30
- FDA Inspection 850538 - 2013-09-27
- FDA Inspection 739997 - 2011-08-17
- [FDA Inspection 642601 - 2010-02-01](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/b747dcd8-092f-4382-b105-174465c7427f)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/nancy-l-neiger/c3209528-eeb3-4a5f-88b1-f503798ed4c5)

Company: https://www.keypedia.com/companies/biomat-usa-inc/8d467793-190c-4d5e-b7be-2edd165543c6

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d